Ranolaz OD 1000mg Tablet ER

  • Manufacturer : Torrent Pharmaceuticals Ltd.
  • Composition : Ranolazine 1000mg
  • Generally Prescribed For : Chronic Angina
  • Estimated Price : 178.00 For 10 Tablets Strip

BUY FROM THESE SELLERS

Uses of Ranolaz OD 1000mg Tablet ER

Ranolaz OD 1000mg Tablet ER is used for the treatment or prevention of the following disease(s):

Chronic Angina

Side effects of Ranolaz OD 1000mg Tablet ER

The most common side effects of Ranolaz OD 1000mg Tablet ER are - Dizziness, Headache, Hypoesthesia, Constipation, Nausea, Vomiting, Angioedema

These side effects can usually occur in patients. However, these are only indicative and not all patients will experience them.

Precautions while using Ranolaz OD 1000mg Tablet ER

Do not use Ranolaz OD 1000mg Tablet ER if you are allergic to - Ranolazine

If you have heart disease, liver or kidney disease, drug or alcohol addiction, consult your doctor before using Ranolaz OD 1000mg Tablet ER.

If you are allergic to any medicine or food, consult your doctor before using this medicine.

Use this medicine under the supervision of your doctor.

To avoid an adverse reaction, consult your doctor if you are already taking other medicines.

How Ranolaz OD 1000mg Tablet ER works

Ranolaz OD 1000mg Tablet ER contains - Ranolazine

Ranolazine helps the heart to relax, improving blood flow to the heart muscle and relieving the symptoms of angina pectoris.

Dosage of Ranolaz OD 1000mg Tablet ER

The dosage of Ranolaz OD 1000mg Tablet ER depends on many factors such as the patient age, health, medical condition or history of the patient and many other conditions.

Please use this medicine as prescribed by your doctor.

Overdose of Ranolaz OD 1000mg Tablet ER

If you forget to take a dose of Ranolaz OD 1000mg Tablet ER, do not take two doses at the same time, there is a risk of overdose.

If you notice any unusual reaction in your body after taking this medicine, contact your doctor immediately or call your local medical emergency number.

Precautions & Warnings

  • ...
  • Alcohol Information will be added soon.

  • ...
  • Pregnancy Information will be added soon.

  • ...
  • Breastfeeding Information will be added soon.

  • ...
  • Driving Information will be added soon.

  • ...
  • Kidney Information will be added soon.

  • ...
  • Liver Information will be added soon.

Alternate Brands

For informational purposes only. Consult a doctor before taking any medicines.

Ranozex 1000mg Tablet ER
Sun Pharmaceutical Industries Ltd.
170.00
10 Tablets Strip Tablets Strip
View all alternate brands

Interaction

Drug :- CYP3A inducers, such as carbamazepine, phenobarbital, phenytoin, rifabutin, rifampin, rifapentin, St. John's wort: Decreased blood ranolazine level and decreased effectiveness.

CYP3A substrates, such as cyclosporine: Possibly increased cyclosporine level.

CYP3A inhibitors, such as clarithromycin, diltiazem, indinavir, itraconazole, ketoconazole, nefazodone, nelfinavir, ritonavir, saquinavir, verapamil: Increased blood ranolazine level and increased risk of adverse reactions.

digoxin: Increased blood digoxin level.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

About Author

  • Dr. Swaroop Choudhari, MD
  • Dr. Swaroop Choudhari, MD Dr. Swaroop Y Choudhari is an MBBS, MD in General Medicine. The doctor holds an experience of 8 years, and has extensive knowledge in his respective f...
    ... ...

    Dr. Swaroop Choudhari, MD Dr. Swaroop Y Choudhari is an MBBS, MD in General Medicine. The doctor holds an experience of 8 years, and has extensive knowledge in his respective field of medicine.
    ... ...

About Author

  • Kunal V Kumar, B.Pharma
  • Kunal V Kumar, B.Pharma Kunal is a registered pharmacist with RGUHS with over 11 months experience. He is a medicine content contributor at Zotezo....

    Kunal V Kumar, B.Pharma Kunal is a registered pharmacist with RGUHS with over 11 months experience. He is a medicine content contributor at Zotezo.

ZOTEZO IN THE NEWS

...